BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 12754707)

  • 1. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy.
    Tuffery-Giraud S; Saquet C; Chambert S; Claustres M
    Hum Mutat; 2003 Jun; 21(6):608-14. PubMed ID: 12754707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
    Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
    Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
    Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
    Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.
    Suminaga R; Takeshima Y; Adachi K; Yagi M; Nakamura H; Matsuo M
    J Hum Genet; 2002; 47(4):196-201. PubMed ID: 12166656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cryptic exons identified in introns 2 and 3 of the human dystrophin gene with duplication of exons 8-11.
    Ishibashi K; Takeshima Y; Yagi M; Nishiyama A; Matsuo M
    Kobe J Med Sci; 2006; 52(3-4):61-75. PubMed ID: 16849873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center.
    Takeshima Y; Yagi M; Okizuka Y; Awano H; Zhang Z; Yamauchi Y; Nishio H; Matsuo M
    J Hum Genet; 2010 Jun; 55(6):379-88. PubMed ID: 20485447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophy. Mutations in brief no. 213. Online.
    Ikezawa M; Nishino I; Goto Y; Miike T; Nonaka I
    Hum Mutat; 1999; 13(2):170. PubMed ID: 10094556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
    Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
    Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel splice site mutation (3157+1G>T) in the dystrophin gene causing total exon skipping and DMD phenotype.
    Sironi M; Corti S; Locatelli F; Cagliani R; Comi GP
    Hum Mutat; 2001 Mar; 17(3):239. PubMed ID: 11241855
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations?
    Khelifi MM; Ishmukhametova A; Khau Van Kien P; Thorel D; Méchin D; Perelman S; Pouget J; Claustres M; Tuffery-Giraud S
    Hum Mutat; 2011 Apr; 32(4):467-75. PubMed ID: 21305657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects.
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Hum Mutat; 1999; 14(5):359-68. PubMed ID: 10533061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.
    Daoud F; Angeard N; Demerre B; Martie I; Benyaou R; Leturcq F; Cossée M; Deburgrave N; Saillour Y; Tuffery S; Urtizberea A; Toutain A; Echenne B; Frischman M; Mayer M; Desguerre I; Estournet B; Réveillère C; Penisson-Besnier ; Cuisset JM; Kaplan JC; Héron D; Rivier F; Chelly J
    Hum Mol Genet; 2009 Oct; 18(20):3779-94. PubMed ID: 19602481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
    Anand A; Prabhakar S; Kaul D
    Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
    Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
    Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation spectrum leading to an attenuated phenotype in dystrophinopathies.
    Tuffery-Giraud S; Saquet C; Thorel D; Disset A; Rivier F; Malcolm S; Claustres M
    Eur J Hum Genet; 2005 Dec; 13(12):1254-60. PubMed ID: 16077730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
    Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
    Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation.
    Wilton SD; Johnsen RD; Pedretti JR; Laing NG
    Am J Med Genet; 1993 Jun; 46(5):563-9. PubMed ID: 8322822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.